Why is Zenotech Lab. falling/rising?

As of 08-Sep, Zenotech Laboratories Ltd is currently priced at 55.75, reflecting a slight increase of 0.09 or 0.16%. The stock has shown a consecutive gain over the last two days, rising by 0.36% during this period. However, it is trading below its moving averages across various time frames, indicating a potential weakness in momentum. The stock has underperformed significantly over the past year, with a decline of 29.57%, and its net sales have decreased by 10.4% compared to previous quarters. Despite a strong ability to service debt, indicated by a low Debt to EBITDA ratio of 0.90 times, the overall poor long-term growth and negative recent financial results contribute to a bearish outlook for the stock. In the broader market context, the Sensex has shown a positive return of 0.53% over the past week, contrasting with Zenotech's decline of 1.15% during the same period. This underperformance against the benchmark highlights the stock's struggles relative to the overall market. Additionally, the stock's liquidity appears to be declining, with a significant drop in delivery volume, which may further deter investor interest. Overall, while there are some positive aspects such as the company's ability to manage debt, the negative financial performance and underwhelming growth prospects suggest that Zenotech Laboratories Ltd is facing challenges that could hinder its stock price recovery.